PMDI (Psychemedics) Debt-to-Equity: 0.23 (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PMDI Psychemedics Corp PMDI
58 GF Score
Price $2.49
View Full Analysis

What is Psychemedics Debt-to-Equity?

Psychemedics PMDI +13.18% 58 Debt-to-Equity is 0.23 as of Dec. 2024. GuruFocus rates PMDI with a GF Score™ of 58/100.

Psychemedics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $0.69 Mil. Psychemedics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $0.48 Mil. Psychemedics's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $5.13 Mil. Psychemedics's debt to equity for the quarter that ended in Dec. 2024 was 0.23.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Psychemedics's Debt-to-Equity or its related term are showing as below:

PMDI's Debt-to-Equity is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.275
* Ranked among companies with meaningful Debt-to-Equity only.

Psychemedics  (OTCPK:PMDI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Psychemedics Debt-to-Equity Related Terms

Psychemedics Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Psychemedics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Psychemedics Debt-to-Equity Chart

Psychemedics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.71 0.42 0.33 0.34 0.23

Psychemedics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.31 0.33 0.29 0.23

PMDI vs MBAI, MYNZ, ADVB: Debt-to-Equity Comparison

For the Diagnostics & Research subindustry, Psychemedics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Psychemedics Debt-to-Equity vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Psychemedics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Psychemedics's Debt-to-Equity falls into.


PMDI
58GF Score
Psychemedics Corp PMDI
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Psychemedics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Psychemedics's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.689 + 0.477) / 5.13
=0.23

Psychemedics's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.689 + 0.477) / 5.13
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of 0.23 mean?
Psychemedics (PMDI) has a Debt-to-Equity of 0.23 as of Dec. 2024. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Psychemedics and its competitors.
Is Psychemedics' Debt-to-Equity too high?
Psychemedics' current Debt-to-Equity is 0.23. The Medical Diagnostics & Research industry median Debt-to-Equity is 0.28. Psychemedics' value of 0.23 is 16.4% below this industry median. Overall, Psychemedics has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Psychemedics' Debt-to-Equity compare to MBAI and MYNZ?
Psychemedics' Debt-to-Equity of 0.23 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Debt-to-Equity is 0.28. Psychemedics' value of 0.23 is 16.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Diagnostics & Research company?
The median Debt-to-Equity among Medical Diagnostics & Research companies is 0.28, based on 180 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Psychemedics's current Debt-to-Equity of 0.23 is 16.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Psychemedics and its competitors. For the Medical Diagnostics & Research industry, the median Debt-to-Equity is 0.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Psychemedics's current Debt-to-Equity is 0.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Psychemedics stock overvalued right now?
Psychemedics (PMDI) has a current Debt-to-Equity of 0.23. The current Debt-to-Equity is 0.23 and 16.4% below the Medical Diagnostics & Research industry median of 0.28. Psychemedics' overall GF Score™ is 58/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Psychemedics (PMDI), the current Debt-to-Equity is 0.23 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Psychemedics Business Description

Address 5220 Spring Valley Road, Suite 230, Dallas, TX, USA, 75254
Psychemedics Corp provides testing services for the detection of drug abuse and other health markers through the analysis of hair samples. The company generates revenue mainly from providing drug and alcohol testing services for its customers for an agreed-upon fee per unit tested. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in it without destroying the drugs. Geographically, the majority of its revenue comes from the United States, and also has a presence in other markets.
58GF Score

Get the complete analysis for PMDI

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.49
Price